VC  Morgan Stanley Expansion Capital pansion-capital/index.html

     Office Locations:

1585 Broadway, 39th Floor
New York, NY 10036
Phone: 212-761-8753
Fax: 212-507-3971



  • Expansion
  • Growth



  • Consumer Products & Services
  • Information Technology
  • Life Sciences & Healthcare
  • Media & Digital Media
  • Software & Internet



    Morgan Stanley Expansion Capital invests in later-stage, private emerging growth companies in technology and other high growth sectors including healthcare, consumer and digital media. Morgan Stanley has a long and successful history growth investing. Since 1986, Expansion Capital and its predecessor, Morgan Stanley Venture Partners, have invested over $1.1 billion of growth capital in over 150 companies. The firm has offices in New York and San Francisco. Expansion Capital targets later-stage investments in technology, healthcare, consumer, digital media, and other high growth sectors. We seek companies largely beyond the development-risk phase and that have demonstrated customer and market validation. While the firm does not require profitable operations for prospective investments, capital efficiency is emphasized. Morgan Stanley targets a $5 - 15 million investment.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Debra Abramovitz Executive Director
    Lincoln Isetta Managing Principal
    Melissa Daniels Managing Principal
    Pete Chung Managing Director
    Robert Bassman Executive Director


    Recent Funding Events (trailing 12 months):







      VBrick Systems








      Series D







    Portfolio companies include:

      Arcadian Management
        web link

      Clinipace Worldwide
        web link

        web link

        web link

        web link

        web link

        web link

      Emphasys Medical
        web link

        web link

        web link

      Internp Network Services
        web link

        web link

        web link

      NanoString Technologies
        web link

      National Healing
        web link

        web link

        web link

      Plateau Systems
        web link

        web link

        web link

      Solstice Neurosciences
        web link

      Soma Networks
        web link

        web link

        web link

      TriVirix International
        web link

      U.S. HealthWorks
        web link

      VBrick Systems
        web link

        web link


    Recent News: